Origo Biopharma

Biotech company from Barcelona developing a new generation of therapeutic products for the treatment of several diseases linked to TGF-β in gastrointestinal and lung indications.

Founded by biotech/pharma executives from Palobiopharma and Galchimia.

Team

TYPE

Biotech; tissue-restricted TGFb inhibitors  for GI and lung indications

WEBSITE

origobiopharma.com

LOGO